Skip to main content
Signal8

Celebi John

SEC insider (Form 3/4/5 filer). CIK 0001843539. PRESIDENT AND CEO at Sensei Biotherapeutics, Inc. (SNSE). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 19, 2025. Located in ROCKVILLE, MD.

Companies Celebi John has filed insider reports for

  • Sensei Biotherapeutics, Inc. (SNSE): Director, Officer, PRESIDENT AND CEO
Celebi John profile photo

Celebi John

CIK: 0001843539

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Sensei Biotherapeutics, Inc. logo
SNSE

Sensei Biotherapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Sensei Biotherapeutics, Inc. logo
    SNSE

    Sensei Biotherapeutics, Inc.

    Feb 19, 2025
    Tax Payment
    Direct
    5.6K shares at avg. $0.48$3K
  • Sensei Biotherapeutics, Inc. logo
    SNSE

    Sensei Biotherapeutics, Inc.

    Feb 14, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    360K shares-
  • Sensei Biotherapeutics, Inc. logo
    SNSE

    Sensei Biotherapeutics, Inc.

    Dec 20, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    355K shares-

1-3 of 3